BAL bellamy's australia limited
Add to My Watchlist 0.00% ! $13.23

Fundamentals

  1. 8horse
    34,472 Posts.
    lightbulb Created with Sketch. 9419
    clock Created with Sketch.
    16/08/18
    12:08
    Post #: 34975434
    BAL, has been smashed down around 60% from recent high, punished for the delay of SAMR approval.

    However, BAL expects 2018 annual revenue to be around $312m - $324m with EBITDA of 21-23%.
    BAL's infant formula revenue for 2018 year would be around A$300m,
    A2M's infant formula revenue for 2018 year would be around A$720m, EBITDA of 30%, with CFDA/SAMR approval.

    A2M's market cap is Seven times of BAL's.

    BAL does have organic certificate to apply for CNCA, also the source of organic powder is an issue.
    Last edited by 8horse: 16/08/18
    BAL Price at posting: $9.06 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS Kameelburg Niobium and REE mineralisation extends to 1,350 Meters
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist
right-arrow Created with Sketch.
NEWS Transformative PV solar recycling acquisition completed
right-arrow Created with Sketch.
NEWS Update on exploration at Fosterville and Glenlogan
right-arrow Created with Sketch.
NEWS High-grade copper identified at Nejo Gold Project, Ethiopia
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.